The MFDS reviews New Drug Applications for safety and efficacy by examining clinical trial data, including study design, methodologies, and results. The agency assesses risk-benefit profiles, evaluates adverse event data, and may consult expert panels. This thorough evaluation ensures that only drugs meeting rigorous safety and efficacy standards are approved for public use.
